Watch Ticker

Lyra Therapeutics, Inc. Common Stock

Go to Lyra Therapeutics, Inc. Common Stock Website

$6.75

0.00 (0.00%)

Live

Previous Close

$6.75

Day Range

$0 - $0

Previous Day Range

$6.5441 - $7.2

Market Cap

$10.9 million USD

Day Vol.

Previous Day Vol.

35002

Currency

USD

Primary Exchange

Nasdaq

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

Lyra Therapeutics reported positive results from the ENLIGHTEN 2 Phase 3 trial of LYR-210, a treatment for chronic rhinosinusitis. The trial met its primary and key secondary endpoints, demonstrating statistically significant improvements in symptoms compared to sham control.

Related tickers: LYRA.

Read Full Article

N/A - Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Lyra Therapeutics plans to present positive 52-week results from the Extension Stage of the ENLIGHTEN 1 Phase 3 study for its lead product candidate LYR-210 in treating chronic rhinosinusitis. The results support LYR-210's favorable safety profile and durable symptom control.

Related tickers: LYRA.

Read Full Article

Trending Tickers

Please sign in to view